Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

Share Price is delayed by 15 minutes
Get Live Data
593.80    -7.60 (-1.26%)
Bid:
593.60
Ask:
594.00
Spread: 0.40 (0.067%)
Market Cap: £47.29b
NWG Live PriceLast checked at - London Stock Exchange

Intraday Natwest Share Chart

Directorate Change

6 Feb 2024 09:30

RNS Number : 1830C
NatWest Group plc
06 February 2024

6 February 2024

NatWest Group plc

Directorate Change

NatWest Group plc ('NWG') announces the appointment of Geeta Gopalan as an independent non-executive director with effect from 1 July 2024.

Howard Davies, Chairman of NWG, said:

"I am delighted to welcome Geeta to NatWest Group. Geeta will be a valuable addition to the board, bringing substantial financial and banking expertise, combined with a strong track record as a plc non-executive director."

Geeta currently serves as a non-executive director of Virgin Money UK PLC*, Funding Circle plc, Intrum S.A., and as a Trustee of The Old Vic Theatre. She previously served as a non-executive director of Dechra Pharmaceuticals Ltd, Ultra Electronics Plc, Wizink Bank SA, and Vocalink. Geeta's biography is set out below.

*Stepping down on 30 June 2024.

There are no further matters requiring disclosure under Listing Rule 9.6.13.

For further information contact:

NatWest Group Investor Relations:

Claire Kane

Director, Investor Relations

+44 (0) 20 7672 1758

NatWest Group Media Relations:

+44 (0) 131 523 4205

LEI: 2138005O9XJIJN4JPN90

-------------------------------------------------

Geeta Gopalan Biography

Geeta Gopalan is currently a non-executive director of Virgin Money UK PLC*, serving as Risk Committee Chair; Intrum S.A, Europe's largest credit investment and collections company; Funding Circle plc - the largest fintech platform for SME lending in the UK, serving as Senior Independent Director and Audit Committee Chair; and as Trustee and Finance Committee Chair at The Old Vic Theatre.

Geeta's previous non-executive directorships include Dechra Pharmaceuticals Ltd, a leading FTSE 150 veterinary pharmaceuticals company, serving as Remuneration Committee Chair; Ultra Electronics Plc, a highly specialised software company that supply solutions for defence, transport and aerospace; Wizink Bank SA, a private equity owned digital bank in Spain; Vocalink, the operator for the UK national payments infrastructure; Trustee Pilotlight, an enterprise focused on bringing business skills to the third sector; and as Vice-Chair and Member of the England Committee Big Lottery Fund, which is the largest non-government funder of community development in the UK and one of the largest globally.

Geeta has spent over 20 years in various executive roles across banking and fintechs. Geeta is also a Qualified Chartered Accountant (Chartered Accountants Institute, India).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAKQLBBZLLLBBE
Date   Source Headline
5th Jun 20265:39 pmRNSTransaction in Own Shares
29th May 20265:07 pmRNSTransaction in Own Shares
29th May 20263:03 pmRNSTotal Voting Rights
29th May 20262:00 pmRNSDirector/PDMR Shareholding
22nd May 20266:02 pmRNSTransaction in Own Shares
15th May 20265:22 pmRNSTransaction in Own Shares
14th May 20262:00 pmRNSDirector/PDMR Shareholding
13th May 20267:00 amRNSNatWest Group plc notes rating actions by Fitch
13th May 20267:00 amRNSQ1 2026 Pillar 3
12th May 20262:00 pmRNSDirector/PDMR Shareholding
8th May 20265:25 pmRNSTransaction in Own Shares
7th May 20265:13 pmRNSHolding(s) in Company - Norges Bank
7th May 20262:00 pmRNSDirector/PDMR Shareholding
1st May 20265:37 pmRNSTransaction in Own Shares
1st May 20264:52 pmRNSPublication of a Supplementary Prospectus
1st May 20267:00 amRNSNatWest Group plc Q1 Results 2026
30th Apr 20263:48 pmRNSTotal Voting Rights
28th Apr 20263:03 pmRNSResult of AGM
28th Apr 20262:34 pmRNSResult of AGM
28th Apr 202611:00 amRNSAGM Statement
24th Apr 20265:25 pmRNSTransaction in Own Shares
20th Apr 20265:23 pmRNSDividend Declaration
17th Apr 20265:27 pmRNSTransaction in Own Shares
17th Apr 20263:31 pmRNSNotice of Redemption
10th Apr 20265:30 pmRNSTransaction in Own Shares
31st Mar 20265:00 pmRNSTotal Voting Rights
27th Mar 20265:38 pmRNSTransaction in Own Shares
26th Mar 20263:29 pmRNSHolding(s) in Company - Capital Group Companies
24th Mar 20264:00 pmRNSNotice of AGM
20th Mar 20265:43 pmRNSTransaction in Own Shares
18th Mar 202610:52 amRNSNotice Of Redemption
13th Mar 20265:56 pmRNSTransaction in Own Shares
11th Mar 20262:00 pmRNSDirector/PDMR Shareholding
6th Mar 20265:31 pmRNSTransaction in Own Shares
5th Mar 20265:19 pmRNSTransaction in Own Shares
4th Mar 20265:46 pmRNSTransaction in Own Shares
3rd Mar 20265:10 pmRNSTransaction in Own Shares
2nd Mar 20265:28 pmRNSTransaction in Own Shares
27th Feb 20265:11 pmRNSTransaction in Own Shares
27th Feb 20264:21 pmRNSTotal Voting Rights
27th Feb 20261:38 pmRNSNatWest Group plc Pricing of Securities
26th Feb 20265:18 pmRNSTransaction in Own Shares
25th Feb 20265:29 pmRNSTransaction in Own Shares
24th Feb 20265:33 pmRNSTransaction in Own Shares
24th Feb 20263:03 pmRNSFinal Terms
23rd Feb 20266:09 pmRNSTransaction in Own Shares
20th Feb 20265:27 pmRNSTransaction in Own Shares
19th Feb 20265:59 pmRNSTransaction in Own Shares
18th Feb 20265:27 pmRNSTransaction in Own Shares
18th Feb 20267:00 amRNSFiling of Annual Report on Form 20-F with US SEC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.